Compare GLPI & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GLPI | RVTY |
|---|---|---|
| Founded | 2013 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 11.6B |
| IPO Year | 2013 | 1994 |
| Metric | GLPI | RVTY |
|---|---|---|
| Price | $43.79 | $110.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 16 |
| Target Price | $51.95 | ★ $109.67 |
| AVG Volume (30 Days) | ★ 2.8M | 1.4M |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 6.50% | 0.34% |
| EPS Growth | ★ 2.79 | N/A |
| EPS | ★ 0.82 | 0.36 |
| Revenue | $1,594,752,000.00 | ★ $3,311,822,000.00 |
| Revenue This Year | $9.17 | $6.37 |
| Revenue Next Year | $5.40 | $5.10 |
| P/E Ratio | ★ $52.65 | $311.97 |
| Revenue Growth | ★ 4.13 | N/A |
| 52 Week Low | $41.17 | $81.22 |
| 52 Week High | $49.95 | $118.30 |
| Indicator | GLPI | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 41.51 | 57.54 |
| Support Level | $42.45 | $95.31 |
| Resistance Level | $43.90 | $117.23 |
| Average True Range (ATR) | 0.86 | 3.72 |
| MACD | -0.10 | -0.11 |
| Stochastic Oscillator | 33.48 | 67.72 |
Gaming and Leisure Properties Inc, or GLP, is a self-administered and self-managed Pennsylvania real estate investment trust (REIT). It is engaged in acquiring, financing, and owning real estate property to be leased to gaming operators in triple-net lease arrangements. The company also extends loans that produce fixed or variable returns, which may convert into leased rent upon project completion or stabilization. Its portfolio consists of gaming and related facilities and amenities such as Ameristar Black Hawk, Bally's Casino, Argosy Casino Alton, Bally's Chicago, Hollywood Casino Aurora, and others located across different states in the United States.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.